<?xml version="1.0" encoding="UTF-8"?>
<ref id="B77-vaccines-07-00179">
 <label>77.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shearer</surname>
    <given-names>F.M.</given-names>
   </name>
   <name>
    <surname>Longbottom</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Browne</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Pigott</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Brady</surname>
    <given-names>O.J.</given-names>
   </name>
   <name>
    <surname>Kraemer</surname>
    <given-names>M.U.G.</given-names>
   </name>
   <name>
    <surname>Marinho</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Yactayo</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>de Araujo</surname>
    <given-names>V.E.M.</given-names>
   </name>
   <name>
    <surname>da Nobrega</surname>
    <given-names>A.A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Existing and potential infection risk zones of yellow fever worldwide: A modelling analysis</article-title>
  <source>Lancet Glob. Health</source>
  <year>2018</year>
  <volume>6</volume>
  <fpage>e270</fpage>
  <lpage>e278</lpage>
  <pub-id pub-id-type="doi">10.1016/S2214-109X(18)30024-X</pub-id>
  <pub-id pub-id-type="pmid">29398634</pub-id>
 </element-citation>
</ref>
